# FDA Inspection 1192322 - Triad Rx, Inc - December 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/triad-rx-inc/340467fa-fb05-4a25-bc42-2edfdb5ce1d4
Source feed: FDA_Inspections

> FDA Inspection 1192322 for Triad Rx, Inc on December 08, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192322
- Company Name: Triad Rx, Inc
- Inspection Date: 2022-12-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1192322 - 2022-12-08](https://www.keypedia.com/records/fda_inspections/triad-rx-inc/194b8179-edda-4e33-b02b-7a770b2b173f)
- [FDA Inspection 1018905 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/triad-rx-inc/9d905aaa-f29b-483a-a88d-62b21fe0775c)

Company: https://www.keypedia.com/companies/triad-rx-inc/0f99b7d5-b246-48c1-b8cf-e987b6706d48

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c